MYO-029 is a human anti-GDF-8 monoclonal antibody, which is being developed to treat muscle-wasting diseases including muscular dystrophy and age-related sarcopenia.

Synonyms: MYO-029

This is just here as a test because I lose it

Term information

database cross reference
hasDbXref

PubChem Substance:347910311

Wikipedia:MYO-029

inScheme

https://identifiers.org/drugbank

label

MYO-029

Term relations

Subclass of: